Synergistic interactions of epigallocatechin gallate and oxytetracycline against various drug resistant Staphylococcus aureus strains in vitro
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
23485046
DOI
10.1016/j.phymed.2012.12.010
PII: S0944-7113(12)00517-X
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- čaj chemie MeSH
- erythromycin farmakologie MeSH
- katechin analogy a deriváty farmakologie MeSH
- listy rostlin chemie MeSH
- methicilin rezistentní Staphylococcus aureus účinky léků MeSH
- mikrobiální testy citlivosti MeSH
- mnohočetná bakteriální léková rezistence MeSH
- oxytetracyklin farmakologie MeSH
- rezistence na methicilin MeSH
- rezistence na tetracyklin MeSH
- synergismus léků MeSH
- tetracyklin farmakologie MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antibakteriální látky MeSH
- čaj MeSH
- epigallocatechin gallate MeSH Prohlížeč
- erythromycin MeSH
- katechin MeSH
- oxytetracyklin MeSH
- tetracyklin MeSH
Epigallocatechin gallate (EGCG), the major catechin contained in tea leaves, is known to possess the synergistic anti-staphylococcal activity in combination with various β-lactam antibiotics and tetracycline. In the present study, we explored the in vitro combinatory effect of EGCG in combination with oxytetracycline against eight standard strains and clinical isolates of Staphylococcus aureus, including erythromycin, methicillin and tetracycline resistant strains. The minimum inhibitory concentrations were determined by the broth microdilution assay and the data were evaluated according to the sum of fractional inhibitory concentrations (∑FIC). Our results showed synergistic and additive interactions against all S. aureus strains tested (∑FIC 0.288-0.631), two of which were multidrug resistant. According to our best knowledge, it is the first report on the EGCG synergy with oxytetracycline. Considering its significant synergistic antimicrobial effect and low toxicity, we suggest EGCG as a promising compound for the development of new anti-staphylococcal formulations.
Citace poskytuje Crossref.org
Prenylated phenolics from Morus alba against MRSA infections as a strategy for wound healing